Ceribell (CBLL) Total Non-Current Liabilities (2023 - 2026)
Ceribell's (CBLL) quarterly Total Non-Current Liabilities came in at $21.1 million in Q1 2026, up 1.55% YoY from $20.8 million in Q1 2025, and down 0.92% on a QoQ basis from $21.3 million in Q4 2025.
Ceribell (CBLL) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends
Ceribell (CBLL) has 4 years of Total Non-Current Liabilities data on file, last reported at $21.1 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 1.55% year-over-year to $21.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.1 million (up 1.55% YoY) and the FY2025 annual result came in at $21.3 million, changed 0.09% from the prior year.
- Total Non-Current Liabilities retreated to $21.1 million in Q1 2026, from $21.3 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $22.5 million in Q3 2024 to a low of $2.2 million in Q4 2023.
- A 4-year average of $18.7 million and a median of $20.9 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Non-Current Liabilities jumped 883.26% — and 2025, when it decreased 10.04%.
- Tracing CBLL's Total Non-Current Liabilities over 4 years: stood at $2.2 million in 2023, then jumped by 883.26% to $21.3 million in 2024, then increased by 0.09% to $21.3 million in 2025, then dropped by 0.92% to $21.1 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $21.1 million (Q1 2026), $21.3 million (Q4 2025), and $20.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Ceribell | 921.90 Mn | 792.63 Mn | 25.94 Mn | 20.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.84 Mn |
| Mar 31, 2026 | 21.08 Mn |
| Dec 31, 2025 | 21.28 Mn |
| Sep 30, 2025 | 20.28 Mn |
| Jun 30, 2025 | 20.52 Mn |
| Mar 31, 2025 | 20.76 Mn |
| Dec 31, 2024 | 21.26 Mn |
| Sep 30, 2024 | 22.54 Mn |
| Dec 31, 2023 | 2.16 Mn |